BCM
VTAK icon

Bridgeway Capital Management’s Catheter Precision VTAK Stock Holding History

Bridgeway Capital Management’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3
Closed -$39K – 1359
2021
Q4 		$39K Buy
+3
New +$71.5K ﹤0.01% 1248
2021
Q2 		– Sell
-3
Closed -$154K – 1401
2021
Q1 		$154K Buy
+3
New +$196K ﹤0.01% 1302
2020
Q4 		– Sell
-1
Closed -$48K – 1370
2020
Q3 		$48K Hold
1
– – ﹤0.01% 1299
2020
Q2 		$91K Buy
+1
New +$193K ﹤0.01% 1243

Other funds holding VTAK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BLAM
Bourne Lent Asset Management Pawling, New York $272M AUM 30.95% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bridgeway Capital Management's VTAK Position: Q1 2022 in Review

Bridgeway Capital Management sold out of Catheter Precision (VTAK) in Q1 2022, closing a stake of 3 shares — an estimated $39K sold.

Bridgeway Capital Management first reported a position in VTAK in Q2 2020 and held it in 4 quarters. The position peaked at $154K in Q1 2021. 20 funds tracked by Wall St. Rank hold VTAK as of Q1 2022.

  • Bridgeway Capital Management reported no remaining Catheter Precision position as of Q1 2022 after selling out during the quarter.
  • Bridgeway Capital Management sold 3 Catheter Precision shares in Q1 2022, an estimated $39K.
  • Bridgeway Capital Management first reported a position in Catheter Precision in Q2 2020 and held it in 4 quarters.
  • Bridgeway Capital Management's Catheter Precision position peaked at $154K in Q1 2021.
  • 20 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2022.

Based on Bridgeway Capital Management's 13F filing for Q1 2022, filed 16 May 2022.